✦ LIBER ✦

Immunogenicity of an inactivated Rift Valley fever vaccine in humans: a 12-year experience

✍ Scribed by Phillip R. Pittman; C.T. Liu; Timothy L. Cannon; Richard S. Makuch; Joseph A. Mangiafico; Paul H. Gibbs; Clarence J. Peters

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immunogenicity and safety of an inactiva

✍ Janice M. Rusnak; Paul Gibbs; Ellen Boudreau; Denise P. Clizbe; Phillip Pittman 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 396 KB

Immunogenicity of a recombinant Rift Val

✍ Morrill, John C.; Laughlin, Richard C.; Lokugamage, Nandadeva; Wu, Jing; Pugh, R 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 750 KB

Safety and immunogenicity of recombinant

✍ John C. Morrill; Richard C. Laughlin; Nandadeva Lokugamage; Roberta Pugh; Elena 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 454 KB

Immunogenicity and efficacy of a chimpan

✍ Warimwe, George M; Lorenzo, Gema; Lopez-Gil, Elena; Reyes-Sandoval, Arturo; Cott 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 599 KB

Stability of a formalin-inactivated Rift

✍ N. Lagerqvist; B. Moiane; G. Bucht; J. Fafetine; J.T. Paweska; Å. Lundkvist; K.I 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 581 KB

Efficacy of a Rift Valley fever virus va

✍ G.W. Anderson Jr; J.O. Lee; A.O. Anderson; N. Powell; J.A. Mangiafico; G. Meador 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 481 KB